Promising Results from Potential New MS Treatment Method

High-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells might be the new best way to treat relapsing-remitting multiple sclerosis (MS), especially those cases which are unresponsive to standard treatments. MS is a disease in which a person’s immune system attacks his or her central nervous system. This results in a wide array of symptoms from weakness, to fatigue, to chronic pain. Clinical trial results show that 69 percent of patients who have undergone this treatment, known as high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT), show promising results. Five years post-treatment, participants’ MS has stabilized, and some participants have shown improvements in ability. Given these results, researchers are eager to further investigate the benefits and risks of HDIT/HCT.

Shiva Gopal Vasishta, MD is a Neurology physician in Voorhees, New Jersey, and he also specializes in Psychiatry. Having graduated Government Medical School in 1979 and completed his residency at Boston City Hospital, Dr. Gopal Vasishta has had over 40 years of experience. Dr. Gopal Vasishta is now practicing at Eastern Neurodiagnostic Associates after practicing at Kennedy University Hospital for some years. He remains affiliated with Kennedy Health System Cherry Hill Campus.

Dr. Gopal Vasishta is currently licensed to practice in New Jersey (license number 25MA55133), and he accepts medicare assignments (this means that patients will not be billed for any more than the Medicare deductible and coinsurance). His current practice location is 2301 Evesham Road, Pavilion 800 Suite 209, Voorhees, New Jersey, and he can be reached at his office number (856) 651-0060 for appointments.

Read more about Shiva Gopal Vasishta:

https://about.me/shivagopalvasishta